INS and type 2 diabetes mellitus: SCGN’s involvement in insulin metabolism was further supported by research on SCGN knock-out mice, which demonstrated progressing glucose intolerance most likely due to loss of beta-cell mass [2] and in vivo studies showing differences in SCGN levels between type 2 diabetes mellitus patients and controls [14].